Type 2 diabetes is a chronic condition in which the body’s cells respond poorly to insulin and the pancreas cannot produce enough extra insulin to compensate, so blood glucose stays above the normal range. It accounts for the large majority of diabetes worldwide and usually develops silently over years, passing through a prediabetes stage first. It differs from type 1 diabetes, an autoimmune destruction of the insulin-producing beta cells. Much of what drives type 2 is modifiable.
What it measures
Type 2 diabetes is a diagnosis rather than a single measurement. Three tests are standard: fasting plasma glucose, drawn after at least eight hours without food; Glycated hemoglobin (HbA1c), which reflects average glucose over roughly the previous two to three months and needs no fasting; and the two-hour value of a 75-gram oral glucose tolerance test. A random glucose in the diabetic range alongside classic symptoms – heavy thirst, frequent urination, unexplained weight loss – also counts.
One abnormal result is not enough: guidelines ask for a repeat, or two different abnormal tests from one draw. HbA1c misreads in anemia, hemoglobin variants, recent transfusion, pregnancy and advanced kidney disease, so glucose testing is used instead there. The upstream mechanism, Insulin resistance, is usually present for years before any of these numbers move, because a healthy pancreas hides it by secreting more insulin.
Typical values
These are the American Diabetes Association criteria for adults, in US units with international units in brackets.
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| Fasting plasma glucose | below 100 mg/dL (5.6 mmol/L) | 100-125 mg/dL (5.6-6.9 mmol/L) | 126 mg/dL (7.0 mmol/L) or higher |
| HbA1c | below 5.7% | 5.7-6.4% | 6.5% (48 mmol/mol) or higher |
| Two-hour glucose, 75 g test | below 140 mg/dL (7.8 mmol/L) | 140-199 mg/dL (7.8-11.0 mmol/L) | 200 mg/dL (11.1 mmol/L) or higher |
The diabetes cut-offs are widely shared; the intermediate band is not. The World Health Organization starts impaired fasting glucose higher than the ADA does, and several national bodies use a narrower HbA1c range, so the same result can be called prediabetes in one country and normal in another. Treatment targets are a separate question, and individualized. A fuller walk-through of the diagnosis sits in the reference entry Type 2 diabetes.
Why it matters for longevity
Type 2 diabetes is one of the clearest accelerators of age-related disease. In large pooled cohort analyses it is associated with roughly double the risk of coronary heart disease and stroke, independent of the usual risk factors, and with a loss of several years of life expectancy when diagnosed in middle age – more the younger the diagnosis, less when glucose, blood pressure and lipids are controlled. It remains a leading cause of kidney failure, vision loss in working-age adults and non-traumatic amputation, and cohort data link it to higher dementia risk. Damage tracks with how high glucose runs and for how long, so duration counts as much as today’s number.
What changes it
Body weight is the dominant lever. In randomized primary-care trials of intensive weight management, a substantial share of people with recent-onset type 2 diabetes reached remission – normal glucose off medication – in proportion to how much weight they lost and kept off. Prevention works too: in a large randomized trial in adults with prediabetes, an intensive diet-and-activity program cut progression to diabetes by about 58% over roughly three years, and metformin by about 31%.
Training helps on its own terms: muscle is the body’s main glucose sink, and both aerobic and resistance work improve insulin sensitivity. A short walk after meals blunts the post-meal rise. Fiber-rich, minimally processed eating, fewer sugary drinks, enough sleep and not smoking all move risk the right way. Medication is a real lever, not a failure: metformin is usually first-line, GLP-1 receptor agonists and SGLT2 inhibitors lowered cardiovascular and kidney events in outcome trials, and metabolic surgery produces durable remission in many people with obesity. Age, family history and past gestational diabetes you cannot change – a reason to screen earlier, not to give up on the rest.
Related reading
- How to Improve Metabolic Health: A Practical Guide
- Which Blood Tests Reflect Aging and How to Read Them
- Metformin and Longevity: A Review of the Evidence
- Heart Health: A Prevention Guide for Longevity
Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.